Investigators concluded: “D-limonene selectively attenuated THC-induced anxiogenic effects, suggesting this terpenoid could increase the therapeutic index of THC.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Study subjects reported reduced stress, irritability, and anxiety following CBD dosing.
“It is clear that medical marijuana, when administered safely, can improve an individual’s quality of life,” the study’s authors determined.
Investigators reported that most products’ cannabinoid content fluctuated significantly over time, depending on the storage conditions (time and temperature) of the vape liquids.
“This is the largest study to date to document cannabis product usage patterns and perceived benefits for migraine management.”
Investigators concluded that cannabis treatment “is associated with significant improvements in well-being and quality of life in PTSD.”
Consistent with other studies, researchers concluded, “Adult-use sales were not associated with an increase in lifetime or past 30-day marijuana use.”
Eighty-four percent of those surveyed reported quality of life improvements following their use of cannabis.